Description
Ready-to-use SLAMF7 (CS1) (CRACC) mRNA
For in vitro mRNA transfection and in vivo mRNA delivery by injection
Encodes the SLAMF7 protein (Signaling Lymphocytic Activation Molecule Family member 7, also known as CS1 or CRACC), a cell surface receptor expressed on immune cells including plasma cells, NK cells, and activated T cells – for research and development in the context of immunology, multiple myeloma studies, and development of targeted immunotherapies such as CAR-T or antibody-based treatments
Manufactured by Levostar´s monoPlasmid technology
Designed for optimal expression results:
• Enhanced polyA(+) Stability – for preventing RNA degradation
• Cap1 Structure – for optimal ribosome recruiting
• Carefully selected UTR Regions – to enhance translation initiation
N1-Methylpseudouridine Modification
For enhanced mRNA stability and decreased anti-mRNA immune response Levostar´s catalog mRNAs are in vitro transcribed using N1-Methylpseudouridine (N1-Me-Ψ, N1mpU) by default. If you prefer unmodified mRNA or you require a different modification, please contact us.
Quality Standards: Tested for high purity, low endotoxin, low residual dsRNA & plasmid template DNA, high capping efficiency, and proper polyA(+)-length.
Contents: 1 mg mRNA, lyophilized – also available in solution (1 mg/ml), please inquire
Shipping and Storage: Lyophilized mRNA shipped at room temperature (≤ 25°C). Store at –80°C upon dissolving.
For other mRNA quantities than 1 mg including bulk offers please contact us for pricing
mRNA may also be ordered already encapsulated in Lipid Nanoparticles for high efficiency mRNA delivery – please contact us for a quotation.
For mRNA encapsulation in your lab and subsequent in vitro mRNA transfection or in vivo mRNA delivery we offer Levostar´s portfolio of NeoLNP Kits.
